Expoint - all jobs in one place

The point where experts and best companies meet

Limitless High-tech career opportunities - Expoint

Boston Scientific R&D Technician IV - 1st Shift 
United States, Massachusetts, Marlborough 
303406972

19.07.2024



Your responsibilities will include:

  • Contribute original concepts to the development of advanced prototypes and fixtures.
  • Apply engineering statistics software (i.e., DOE) to characterize processes.
  • Create engineering drawings using Deneba Canvas Graphics and CAD Software and create complete R&D engineering documentation following established procedures. Write and/or verify specifications.
  • Analyze data, calculate statistics, and prepares complete product test reports.
  • Validate equipment and new processes.
  • Maintain complex test equipment, train staff on its operations, and schedule necessary calibration or preventative maintenance.
  • Actively participate in project team meetings. Coordinate and monitor project task execution and project progress against deliverables.
  • Identify additional or new vendors to identify and acquire necessary supplies, materials, equipment and tools for specific projects.


Required qualifications:

  • 6 Years with Associate in Arts degree/diploma, or an equivalent combination of education/work experience

Please be advised that certain US based positions, including without limitation field sales and service positions that call on hospitals and/or health care centers, require acceptable proof of COVID-19 vaccination status. Candidates will be notified during the interview and selection process if the role(s) for which they have applied require proof of vaccination as a condition of employment. Boston Scientific continues to evaluate its policies and protocols regarding the COVID-19 vaccine and will comply with all applicable state and federal law and healthcare credentialing requirements. As employees of the Company, you will be expected to meet the ongoing requirements for your roles, including any new requirements, should the Company’s policies or protocols change with regard to COVID-19 vaccination.